ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2942

Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease

Patrick Coit1, Gonca Mumcu2, Filiz Ture Ozdemir3, Ali Ugur Unal4, Ugur Alpar5, Nagihan Bostanci6, Tulin Ergun7, Haner Direskeneli4 and Amr Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, 3Marmara University, School of Medicine, Department of Immunology, Istanbul, Turkey, 4Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, 5Faculty of Dentistry, Marmara University, Istanbul, Turkey, 6Division of Periodontology, Department of Dental Medicine, Karolinska Institute, Stockholm, Sweden, 7Department of Dermatology, Faculty of Medicine, Marmara University, Istanbul, Turkey

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome and microbiome

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  Behçet’s disease (BD) is a multisystem inflammatory disorder characterized by recurrent oro-genital ulcers, mucocutaneous lesions and serious organ involvement. The goal of this study was to investigate the structure of the salivary microbiome in patients with BD.

Methods:   Stimulated saliva samples were collected from 31 BD patients and 15 healthy controls, and detailed oral health indices were recorded. In 9 BD patients a second oral health evaluation and saliva collection was performed following dental and periodontal treatment. High-throughput sequencing of the 16S rRNA V4 region in saliva samples was performed. Sequences were rigorously filtered and grouped into phylogenetically-related operational taxonomic units (OTUs), used to measure bacterial community diversity and richness. OTUs were classified using a 16S rRNA reference database at the species-level. AMOVA and LEfSe analyses were used to measure differences between patients and controls at the community- and species-level, respectively.

Results:  Sequence analysis identified a total of 908 OTUs present across all samples. Patients had a microbial community structure that is significantly less diverse than healthy controls. The most overabundant species in BD patients compared to controls was Haemophilus parainfluenzae, while the most depleted included Alloprevotella rava and species in the genus Leptotrichia. Patients receiving periodontal treatment showed improvements in oral health indices, but no short-term differences in bacterial community structure. Neither the BD-associated genetic risk locus within the HLA-B/MICA region nor being on immunosuppressive medications explained the differences between patients and controls.

Conclusion:  This is the first high-throughput sequencing-based evaluation of the salivary microbiome in BD. Salivary microbiome of BD patients has a specific signature characterized by changes at the community and species level.


Disclosure: P. Coit, None; G. Mumcu, None; F. Ture Ozdemir, None; A. U. Unal, None; U. Alpar, None; N. Bostanci, None; T. Ergun, None; H. Direskeneli, None; A. Sawalha, None.

To cite this abstract in AMA style:

Coit P, Mumcu G, Ture Ozdemir F, Unal AU, Alpar U, Bostanci N, Ergun T, Direskeneli H, Sawalha A. Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/sequencing-of-16s-rrna-reveals-a-distinct-salivary-microbiome-signature-in-behcets-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sequencing-of-16s-rrna-reveals-a-distinct-salivary-microbiome-signature-in-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology